Actinium CFO Steve O'Loughlin resigns; CEO Sandesh Seth named principal financial officer

Actinium Pharmaceuticals, Inc.

Steve O'Loughlin resigns as CFO effective Feb 27, 2026 to pursue other opportunities.
No disagreements with the company contributed to his resignation.
Board appoints CEO/Chairman Sandesh Seth as principal financial officer effective same date.
Sandesh Seth has 25+ years in pharma, investment banking, and equity research.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.